ConductScience.org, home

Paper41377495

Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines.

Zimina A and 6 others. bioRxiv, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines. Papers, record 41377495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377495

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines.
PubMed
Journal
bioRxiv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zimina AAnna
2Kouiavskaia DDiana
3Viktorova EGEkaterina G
4Moghimi SSeyedehmahsa
5Chumakov KKonstantin
6Rosenfeld ABAmy B
7Belov GAGeorge Ahttps://orcid.org/0000-0002-0892-1731

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 AI153976NIAID NIH HHSUnited StatesR21AI153976PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132330425Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.Cell Host Microbe2020https://conductscience.org/library/papers/32330425PubMed
235999326Recent changes to virus taxonomy ratified by the International Committee on Taxonomy of Viruses (2022).Arch Virol2022https://conductscience.org/library/papers/35999326PubMed
37832641Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.Arch Virol1994https://conductscience.org/library/papers/7832641PubMed
41846972Transgenic mice susceptible to poliovirus.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1846972PubMed
518770579Newcastle disease virus: propagation, quantification, and storage.Curr Protoc Microbiol2006https://conductscience.org/library/papers/18770579PubMed
67022155Picornaviral structure and assembly.Microbiol Rev1981https://conductscience.org/library/papers/7022155PubMed
730483226Enterovirus D68 - The New Polio?Front Microbiol2018https://conductscience.org/library/papers/30483226PubMed
831540135Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process.Viruses2019https://conductscience.org/library/papers/31540135PubMed
92842953Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor.Virology1988https://conductscience.org/library/papers/2842953PubMed
1028103317Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines.PLoS Pathog2017https://conductscience.org/library/papers/28103317PubMed
111316678Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells.Virology1992https://conductscience.org/library/papers/1316678PubMed
1230482835Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.mBio2018https://conductscience.org/library/papers/30482835PubMed
1319428874Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.Vaccine2009https://conductscience.org/library/papers/19428874PubMed
1428811473Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine.Nat Commun2017https://conductscience.org/library/papers/28811473PubMed
1539543143A highly immunogenic UVC inactivated Sabin based polio vaccine.NPJ Vaccines2024https://conductscience.org/library/papers/39543143PubMed
1629512114Poliovirus Replicon RNA Generation, Transfection, Packaging, and Quantitation of Replication.Curr Protoc Microbiol2018https://conductscience.org/library/papers/29512114PubMed
1732768520Vero cell upstream bioprocess development for the production of viral vectors and vaccines.Biotechnol Adv2020https://conductscience.org/library/papers/32768520PubMed
1816568900Evolution of virulence in picornaviruses.Curr Top Microbiol Immunol2006https://conductscience.org/library/papers/16568900PubMed
1939827284Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.Nat Commun2025https://conductscience.org/library/papers/39827284PubMed
2030940708Acute Flaccid Myelitis: Something Old and Something New.mBio2019https://conductscience.org/library/papers/30940708PubMed

See all 49 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41377495

GET https://conductscience.org/api/papers/v1/41377495/references?page=2